anmelden
FTSE All-Share
5.504,53
PKT
-21,74
PKT
-0,39
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.04.26 | GSK Hold | Deutsche Bank AG | |
| 30.04.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 30.04.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.04.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 30.04.26 | GSK Underweight | Barclays Capital | |
| 30.04.26 | Unilever Outperform | Bernstein Research | |
| 30.04.26 | GSK Neutral | Goldman Sachs Group Inc. | |
| 29.04.26 | GSK Halten | DZ BANK | |
| 29.04.26 | AstraZeneca Kaufen | DZ BANK | |
| 29.04.26 | BP Buy | Goldman Sachs Group Inc. | |
| 29.04.26 | Unilever Hold | Deutsche Bank AG | |
| 29.04.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 29.04.26 | AstraZeneca Overweight | Barclays Capital | |
| 29.04.26 | BP Overweight | Barclays Capital | |
| 29.04.26 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 28.04.26 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 28.04.26 | BP Hold | Jefferies & Company Inc. | |
| 28.04.26 | BP Kaufen | DZ BANK | |
| 28.04.26 | BP Buy | UBS AG | |
| 28.04.26 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 28.04.26 | BP Sector Perform | RBC Capital Markets | |
| 28.04.26 | BP Overweight | Barclays Capital | |
| 28.04.26 | BP Neutral | JP Morgan Chase & Co. | |
| 28.04.26 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 27.04.26 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 27.04.26 | Unilever Overweight | Barclays Capital | |
| 27.04.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 24.04.26 | BP Overweight | Barclays Capital | |
| 24.04.26 | National Grid Sell | UBS AG | |
| 24.04.26 | London Stock Exchange (LSE) Buy | UBS AG | |
| 24.04.26 | London Stock Exchange (LSE) Buy | Deutsche Bank AG | |
| 24.04.26 | London Stock Exchange (LSE) Outperform | RBC Capital Markets | |
| 24.04.26 | London Stock Exchange (LSE) Overweight | JP Morgan Chase & Co. | |
| 23.04.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.04.26 | HSBC Overweight | Barclays Capital | |
| 23.04.26 | London Stock Exchange (LSE) Buy | UBS AG | |
| 23.04.26 | London Stock Exchange (LSE) Buy | Jefferies & Company Inc. | |
| 23.04.26 | BP Sector Perform | RBC Capital Markets | |
| 23.04.26 | London Stock Exchange (LSE) Outperform | RBC Capital Markets | |
| 23.04.26 | London Stock Exchange (LSE) Buy | Goldman Sachs Group Inc. |